CLP recently spoke with David Hout, PhD, VP of R&D, Insight Genetics, about continuing work on the Insight ALK Screen, Insight ALK Resistance, and other biomarker-specific diagnostic tools to advance cancer care.
Read More
Researchers have now developed and tested a promising new method for screening ALK fusions in NSCLC.
Read More
The test detects all types and all stages of lung cancer, including Stage I and II.
Read More
Ronnie Andrews, Life Technologies’ president of medical sciences, has shepherded multiple acquisitions and product launches as Life continues to expand its presence in the world of clinical diagnostics. Here he looks back at 2012, and ahead to 2013.
Read More
State-of-the-art medical research institute will bring new hope to young patients facing life-threatening diseases with sophisticated genomic analysis and real-time access to drugs.
Read More